Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Feasibility and Utility of a Structured Guide for Cannabis Tolerance Breaks in Young Adults

View ORCID ProfileThomas JK Fontana, Jonathan A. Schulz, View ORCID ProfileAlan J. Budney, View ORCID ProfileAndrea C. Villanti
doi: https://doi.org/10.1101/2022.05.18.22274748
Thomas JK Fontana
1Center for Health & Wellbeing, University of Vermont, Burlington, VT, USA
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Thomas JK Fontana
  • For correspondence: tom.fontana{at}uvm.edu
Jonathan A. Schulz
2Vermont Center on Behavior and Health, Department of Psychiatry, University of Vermont, Burlington, VT, USA
PhD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alan J. Budney
3Center for Technology and Behavioral Health, Geisel School of Medicine at Dartmouth, Dartmouth College, Lebanon, NH, USA
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alan J. Budney
Andrea C. Villanti
2Vermont Center on Behavior and Health, Department of Psychiatry, University of Vermont, Burlington, VT, USA
4Department of Health Behavior, Society, and Policy, Rutgers School of Public Health and Rutgers Center for Tobacco Studies, New Brunswick, NJ, USA
PhD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Andrea C. Villanti
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

Objective To explore the feasibility and utility of a tolerance break (T-Break) guide on young adults’ cannabis use.

Participants Young adults aged 18-29 (n=125) who were current cannabis users.

Methods Participants recruited through posters and listservs at various universities were offered the T-Break Guide—daily activities, advice, and encouragement—to help complete a 21-day cannabis break. Bivariate analyses examined associations between Guide use and follow-up measures.

Results Compared to non-Guide users, participants who used the Guide “a lot” were more likely to complete the 21-day abstinence break (84% vs. 57%), revise their personal definition of balance to mean less cannabis (84% vs. 62%), and plan a future break (32% vs. 11%).

Conclusion Use of this self-directed Guide may help young adults take a break from cannabis use and reduce future use. Further research using more rigorous designs to test the Guide’s efficacy and assess longer-term maintenance of effects is needed.

Competing Interest Statement

This research was funded by a grant from the State of Vermont (TF). Effort of the authors was also supported by the National Institute on Drug Abuse of the National Institutes of Health under award numbers U54DA036114 (JAS), R21DA051943 (ACV), and P30DA029926 (AJB). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the State of Vermont. TF is the owner of Cum Laude Consulting LLC, which received a grant from the State of Vermont to investigate the T-Break Guide. Those funds were then subcontracted to the University of Vermont for this research.

Clinical Trial

NCT05382273

Funding Statement

This research was funded by a grant from the State of Vermont (TF). Effort of the authors was also supported by the National Institute on Drug Abuse of the National Institutes of Health under award numbers U54DA036114 (JAS), R21DA051943 (ACV), and P30DA029926 (AJB). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the State of Vermont.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

IRB of University of Vermont gave ethical approval for this work (STUDY00001489)

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Conflict of Interest: This research was funded by a grant from the State of Vermont (TF). Effort of the authors was also supported by the National Institute on Drug Abuse of the National Institutes of Health under award numbers U54DA036114 (JAS), R21DA051943 (ACV), and P30DA029926 (AJB). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the State of Vermont.

  • Financial Disclosure: TF is the owner of Cum Laude Consulting LLC, which received a grant from the State of Vermont to investigate the T-Break Guide. Those funds were then subcontracted to the University of Vermont for this research.

Data Availability

All data produced are available online at https://doi.org/10.7910/DVN/RQZQ1Q

https://doi.org/10.7910/DVN/RQZQ1Q

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted May 23, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Feasibility and Utility of a Structured Guide for Cannabis Tolerance Breaks in Young Adults
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Feasibility and Utility of a Structured Guide for Cannabis Tolerance Breaks in Young Adults
Thomas JK Fontana, Jonathan A. Schulz, Alan J. Budney, Andrea C. Villanti
medRxiv 2022.05.18.22274748; doi: https://doi.org/10.1101/2022.05.18.22274748
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Feasibility and Utility of a Structured Guide for Cannabis Tolerance Breaks in Young Adults
Thomas JK Fontana, Jonathan A. Schulz, Alan J. Budney, Andrea C. Villanti
medRxiv 2022.05.18.22274748; doi: https://doi.org/10.1101/2022.05.18.22274748

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Addiction Medicine
Subject Areas
All Articles
  • Addiction Medicine (430)
  • Allergy and Immunology (756)
  • Anesthesia (221)
  • Cardiovascular Medicine (3294)
  • Dentistry and Oral Medicine (364)
  • Dermatology (279)
  • Emergency Medicine (479)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1171)
  • Epidemiology (13376)
  • Forensic Medicine (19)
  • Gastroenterology (899)
  • Genetic and Genomic Medicine (5153)
  • Geriatric Medicine (482)
  • Health Economics (783)
  • Health Informatics (3268)
  • Health Policy (1140)
  • Health Systems and Quality Improvement (1190)
  • Hematology (431)
  • HIV/AIDS (1017)
  • Infectious Diseases (except HIV/AIDS) (14629)
  • Intensive Care and Critical Care Medicine (913)
  • Medical Education (477)
  • Medical Ethics (127)
  • Nephrology (523)
  • Neurology (4925)
  • Nursing (262)
  • Nutrition (730)
  • Obstetrics and Gynecology (883)
  • Occupational and Environmental Health (795)
  • Oncology (2524)
  • Ophthalmology (724)
  • Orthopedics (281)
  • Otolaryngology (347)
  • Pain Medicine (323)
  • Palliative Medicine (90)
  • Pathology (543)
  • Pediatrics (1302)
  • Pharmacology and Therapeutics (550)
  • Primary Care Research (557)
  • Psychiatry and Clinical Psychology (4212)
  • Public and Global Health (7504)
  • Radiology and Imaging (1706)
  • Rehabilitation Medicine and Physical Therapy (1013)
  • Respiratory Medicine (980)
  • Rheumatology (480)
  • Sexual and Reproductive Health (497)
  • Sports Medicine (424)
  • Surgery (548)
  • Toxicology (72)
  • Transplantation (236)
  • Urology (205)